Shorter Six-Month Oral Regimens For Drug-Resistant TB Prove Cost-Effective: ICMR Study
ICMR study shows shorter six-month oral regimens for drug-resistant TB improve outcomes while lowering treatment costs and easing pressure on the health system.
ICMR study shows shorter six-month oral regimens for drug-resistant TB improve outcomes while lowering treatment costs and easing pressure on the health system.
